DONATE

Samuel Sanchez

Group leader

La Vanguardia: Una sola dosis de nanorrobots aniquila un 90% del tumor en cáncer de vejiga

Un ejército de nanorrobots circula utilizando como combustible urea. Su misión: transportar radiación para atacar las células malignas de la vejiga. No es ciencia ficción, sino el avance que han logrado Meritxell Serra-Casablancas y Samuel Sánchez en el Institut de Bioenginyeria de Catalunya (IBEC), y que han publicado en Nature Nanotechnology. Su estudio ha demostrado que estos nanorrobots tienen una alta eficacia para reducir el volumen de los tumores en ratones.

IBEC and ICMS meet again in Eindhoven for their annual joint symposium

The joint ICMS-IBEC-MPIP symposium took place today, 24 March. The event was jointly organised by the Institute for Bioengineering of Catalonia (IBEC), the Institute for Complex Molecular Systems (ICMS) and the Max Planck Institute for Polymer Research (MPIP). During the day, researchers from the three centres presented their areas of research, with the aim of strengthening the scientific relations between the institutions.

IBEC takes part in MWC 2025 with its innovation in digital health and biomedical technology

MWC 2025, the leading international event in technology and connectivity, took place in Barcelona this week. The Institute for Bioengineering of Catalonia was present, showcasing some of its spin-offs and participating in conferences and panels on digital health and technology transfer.

Novel nanomotors improve bladder cancer immunotherapy

A study led by the Institute for Bioengineering of Catalonia (IBEC) and Pohang University of Science and Technology (POSTECH) in South Korea describes the development of urea-powered nanomotors that improve immunotherapy for bladder cancer. The nanomotors activate the immune system more efficiently and exceed the efficacy of currently used treatments, opening up new possibilities in oncology.

IBEC spin-off Nanobots Therapeutics receives IMPACTO grant from the Spanish Association Against Cancer

IBEC spin-off Nanobots Therapeutics has been selected in the AECC’s 2024 call for IMPACTO grants. This is an initiative of the Spanish Association Against Cancer (AECC) aimed at technology-based micro-enterprises and SMEs to accelerate the arrival of new treatments in the clinic. The grants were awarded in Barcelona today.

IBEC stands out at BIST Forum with 4 BIST Ignite projects and a BIST Ignite Award

Today, the BIST Forum, an event that brings together the BIST scientific community, focused this year on the joint initiative of the seven CERCA centres to promote precision medicine in healthy ageing. During the event, the new BIST Ignite projects to promote multidisciplinary research were announced, with IBEC involved in four of the five selected projects. In addition, one of the projects in which IBEC is involved won a BIST Ignite Award.

IBEC and VHIR hold a collaboration day to promote synergies

The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.